Learn More
Medchemexpress LLC TTA-A2 | 953778-63-7 | 99.33% | 378.39 | 10 MG

Supplier: Medchemexpress LLC HY11182810MG
TTA-A2 is a potent, selective, and orally active T-type voltage-gated calcium channel antagonist with reduced pregnane X receptor (PXR) activation. It is equally potent against the Cav3.1 (a1G) and Cav3.2 (a1H) channels. TTA-A2 can be used for the research of a variety of human neurological diseases, including sleep disorders and epilepsy.
- Potent and selective T-type voltage-gated calcium channel antagonist
- Reduced pregnane X receptor activation
- Equally potent against Cav3.1 and Cav3.2 channels
- Useful for research into neurological diseases such as sleep disorders and epilepsy
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.